Unwrapping the drug pricing mystery & understanding solutions

  https://youtu.be/1QaKdAGbiYo Reposting this useful video from the HIV Prevention Justice Alliance: President-elect Trump pledged during his campaign and at his transition press conference to address the skyrocketing price of drugs, joining bipartisan calls for action. However, drug pricing is incredibly complex and hidden behind an impenetrable curtain of secrecy. Are there any solutions to high drug prices that could be implemented quickly by the new administration and Congress? The Fair Pricing Coalition (FPC) along with other various organizations and individuals signed a letter declaring that the upward spiral of drug prices are too high and will further prevent HIV and hepatitis C (HCV) patients from accessing … [Read more...]

The Global Fund has been backing away from efforts to promote generic competition

Reprinted from original source, Global Fund Observer, Issue 284 6 April 2016: The Global Fund has been backing away from efforts to promote generic competition  Fund’s strategy has come under growing scrutiny by Nathalie Abejero With progressively stricter patent protections, the costs for new treatments continue to rise. It is a global problem that affects countries across income levels, but is particularly challenging for poor and transitioning economies. Until recently, The Global Fund has advocated for the affordability, availability, and financing of medicines and other health commodities, taking the time-tested position of promoting generic competition as the most effective means for bringing down the price of … [Read more...]